TF and acute myeloid leukemia: This study used a cohort of 32 AML samples obtained from highly purified populations of undifferentiated cells comprising at least 90% leukemic blasts from AML patients with distinct TF and signaling molecule mutations to define the mechanisms of AML-subtype-specific regulatory circuitries.